Loren Brown has an extensive civil litigation practice with a particular concentration in the pharmaceutical and mass tort areas.

Loren has served as national coordinating counsel, tried jury cases, and argued appeals on behalf of many Fortune 50 companies. He currently acts as national coordinating counsel and lead trial counsel in mass tort and multi-district litigation throughout the US, including litigation involving the Cox 2 anti-inflammatory medications Celebrex and Bextra, the smoking cessation medication Chantix and the hormone therapy medications Prempro and Premarin. He also regularly counsels clients on a wide range of risk management, due diligence, regulatory, product labeling, recall and public disclosure issues.

Loren's business litigation practice includes substantial consumer class action, securities, commercial tort and contract, and intellectual property litigation experience. He also has experience in a range of internal compliance and investigation matters, particularly in the biopharmaceutical and clinical research areas.

Loren is co-chair of the firm’s US Litigation group, its Product Liability and Mass Tort subgroup and a member of the firm's Executive Committee.